Want to join the conversation?
Steve Byrne of Bank of America Merrill Lynch asks about mix shifts in $MON's corn genetic share. COO Brett Begemann said $MON grew its genetic footprint this year. There is strength in some licensing businesses. There is shifting between premium brands in the marketplace every year but $MON expects direct brand share to remain flat.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?